false
ar,zh-CN,zh-TW,en,fr,de,hi,it,ja,es,ur
Catalog
SCAI/MedAxiom Intravascular Imaging Town Hall: Mov ...
Closing Remarks
Closing Remarks
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
year and they still get a 50% reduction in endpoints, how much more benefit would somebody who isn't as experienced to get from knowing the exact size of the stent, knowing how long it needs to be, ensuring that that stent is adequately expanded? And so I think low volume operators, in my opinion, may have more to gain. You know, the inexperience with image interpretation I think is going to potentially be solved by the software. The software, particularly for OCT, is getting so good that it spits out all the relevant information for you. You know, you don't even have to think anymore. You don't have to make measurements. It's all there. And so you just need somebody to educate you on what to look at. And when you see, you know, MSA not hitting what you need or relative expansion not hitting what you need, what do you do next? And it kind of walks you through that. So I think the AI and software are really going to help us solve this issue. So we did have a little bit of a truncated session today because of the previous session. So I'm just going to ask Dr. Schlothmitz to give us a few final parting thoughts. And again, thank you for attending this session. We're really excited about this partnership with MedAxiom and really hope to make a difference. Yep. And I definitely agree with Ryan. Modern intravascular imaging software now has enabled it that if you're doing two PCIs a month, you definitely want to be doing intravascular imaging. And with Ultreon, with SpectraWave system, with Avigo Plus, it walks you through exactly how to do this, that I guarantee you do a 90-minute overview course on this, you'll feel comfortable with the basics, that you'll feel more comfortable actually when you're doing that one PCI every two weeks. So how do we move the needle forward? You know, I think the real motivation and reason why is despite what contemporary stent you're using, we know that one in seven patients are back with a stent-related event in just five years. So there's really a need to do better. One in 10 PCIs in the U.S. are for stent failure. So there's motivation to do better. We know intravascular imaging, as you saw a number of the slides in this session, leads to about 50% reduction in heart events. But it's not just opening the imaging catheter, it's using optimal criteria. So there needs to be that education part of what am I looking for, how do I achieve it. And it doesn't take much time and much effort to do it. If you get just half a millimeter larger area, that's associated with greater than 50% further reduction. And then just one important and final slide, this was presented last month, IBIS-ACS, about 3,500 patients randomized to IBIS or no IBIS. IBIS obviously did a lot better than no IBIS. But what's interesting in the sub-analysis, what they did, they looked at, in blue, angioguided PCI, and then suboptimal PCI with IBIS. And there was no difference, actually, with suboptimal PCI than angioguided PCI. So you need to have specific metrics that you're after, and it's not a lot. It's three simple things. And if you can reach those optimal criteria using intravascular imaging, you see greater than 50% reduction in heart outcomes. So some very straightforward steps to integrate this into your practice, you'll get a much better long-term result for your patients. Ryan has shown this, that it doesn't take a lot of time to change practice on a large scale. The entire state of Michigan, the needle has already moved. So it's the rest of this country now and the rest of the world outside of Japan that needs to follow and be committed to making these changes. And then they also had shown this a couple of times this session, how one of the biggest predictors of will imaging be used is the operator doing it. But what I think is really unbelievable, a couple of lines below it at the bottom, there's a referral for open heart surgery. Disease is bad enough that the physician thinks one of the best ways to manage it is someone taking a power saw to the sternum. But then the patient gets turned down from open heart surgery, comes back to the cath lab, and they don't feel it's necessary to use intravascular imaging for that complexity of disease. So there's a real disconnect there, and it really is going to take a concerted effort to make more physicians comfortable with intravascular imaging so that those physicians will use intravascular imaging. So thank you very much for this session, and I invite anyone to the hands-on imaging training that's taking place downstairs in the exhibit hall. Thank you.
Video Summary
The transcript discusses the benefits of intravascular imaging software, particularly in guiding stent placement and ensuring optimal outcomes for patients undergoing PCI procedures. The use of AI and software can assist in interpreting images and providing relevant information, reducing the need for manual measurements. The importance of education and training on using intravascular imaging is emphasized, as it can lead to a significant reduction in heart events. The session highlights the need to move towards better practices to improve patient outcomes, especially in cases of stent-related events. There is a call for more widespread adoption of intravascular imaging to enhance patient care.
Asset Subtitle
Evan Shlofmitz, D.O.
Keywords
intravascular imaging software
stent placement guidance
PCI procedures
AI in medical imaging
patient outcomes improvement
×